Clinical Trials Directory

Trials / Completed

CompletedNCT00588796

Study of Fibrinogen Metabolism During Severe Trauma and Burns

Alteration in Fibrinogen Metabolism in Patients With Severe Burns and Traumatic Injuries

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
United States Army Institute of Surgical Research · Federal
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

To study the fibrinogen metabolic changes in relation to coagulation disorder in patients with severe burns and trauma injuries. As a result of the burn or trauma injury breakdown of fibrinogen is accelerated.

Detailed description

In this protocol, we will investigate fibrinogen metabolism in burn and trauma patients, using an 8h infusion of stable isotopes labeled amino acids (1-13C-phenylalanine, 2H5-phenylalanine, and 2H3-ketoisocaporate). The increase of the labeled amino acids incorporating into fibrinogen during the infusion and the decay of labeled fibrinogen after stopping the isotopes infusion (as measured by GC-MS) will be used to calculate fibrinogen synthesis and degradation. Stable isotopes are non-radioactive.

Conditions

Timeline

Start date
2005-02-01
Primary completion
2014-01-01
Completion
2014-01-01
First posted
2008-01-09
Last updated
2015-02-04

Source: ClinicalTrials.gov record NCT00588796. Inclusion in this directory is not an endorsement.

Study of Fibrinogen Metabolism During Severe Trauma and Burns (NCT00588796) · Clinical Trials Directory